PTX.AX लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 11:40):

Stats
आज की मात्रा	762 848
औसत मात्रा	1.17M
बाजार मूल्य	41.88M
EPS	$0 ( 2024-02-21 )
Last Dividend	$7.15 ( 1993-10-21 )
Next Dividend	$0 ( N/A )
P/E	-5.20
ATR14	$0.00100 (1.89%)

Prescient Therapeutics सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Prescient Therapeutics वित्तीय

Annual	2023
राजस्व:	$2.43M
सकल लाभ:	$2.43M (99.91 %)
EPS:	$-0.00960

FY	2023
राजस्व:	$2.43M
सकल लाभ:	$2.43M (99.91 %)
EPS:	$-0.00960

FY	2022
राजस्व:	$1.89M
सकल लाभ:	$1.89M (99.93 %)
EPS:	$-0.00790

FY	2021
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-0.00680

Financial Reports:

No articles found.

Prescient Therapeutics Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Prescient Therapeutics Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$5.72	1990-10-25
Last Dividend	$7.15	1993-10-21
Next Dividend	$0	N/A
Payout Date	1993-12-31
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$12.87	--
Avg. Dividend % Per Year	0.00%	--
Score	0.22	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2026-10-05)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.22

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
MVF.AX	Ex Dividend Junior	2023-09-07	Annually	0.00%
WAM.AX	Ex Dividend Knight	2023-10-17	Semi-Annually	0.00%
EGG.AX	Ex Dividend Knight	2023-09-19	Semi-Annually	0.00%
PBH.AX	No Dividend Player	2023-09-06	Insufficient data to determine frequency	0.00%
ALL.AX	Ex Dividend Knight	2023-05-25	Annually	0.00%
GOZ.AX	Ex Dividend Junior	2023-06-29	Semi-Annually	0.00%
REH.AX	Ex Dividend Knight	2023-10-10	Semi-Annually	0.00%
BOQ.AX	Ex Dividend Junior	2023-05-10	Annually	0.00%
KPG.AX	Ex Dividend Knight	2023-07-20	Monthly	0.00%
SPK.AX	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-2.49	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.313	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.318	1.500	-4.65	-6.97	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	10.26	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	9.96	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	3.08	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.00952	2.00	-0.00317	-0.00635	[0 - 30]
freeCashFlowPerShareTTM	-0.00952	2.00	-0.00476	-0.00952	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-3.71	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.126	0.800	-2.50	-1.996	[0.5 - 2]
Total Score				-0.920

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-5.51	1.000	-0.658	0	[1 - 100]
returnOnEquityTTM	-0.318	2.50	-2.99	-6.97	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.00952	2.00	-0.00317	-0.00952	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.00952	2.00	-0.00317	-0.00635	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.911	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-2.46	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.81

Prescient Therapeutics

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.